A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 in Participants ≥6 Months to <12 Years of Age
Public ClinicalTrials.gov record NCT07808697. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Observer-Blind, Dose Ranging Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 in Participants ≥6 Months to <12 Years of Age
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate 2 dose levels of mRNA-1283 in participants ≥6 months to \<12 years to determine the optimal dose level per age group.
Study identification
- NCT ID
- NCT07808697
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Months to 11 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2026
- Primary completion
- Aug 29, 2029
- Completion
- Aug 29, 2029
- Last update posted
- Sep 8, 2026
2026 – 2029
United States locations
- U.S. sites
- 13
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Orange County Research Center | Ontario | California | 91762 | — |
| Hope Research Network | Miami | Florida | 33166 | — |
| Spotlight Research Center - Internal Medicine | Miami | Florida | 33167 | — |
| Indago Research and Health Cen | Miami Lakes | Florida | 33016 | — |
| MplusM - D&H Tamarac Research Center | Tamarac | Florida | 33321 | — |
| Eagle Clinical Research, LLC | Chicago | Illinois | 60621 | — |
| Great Lakes Research Institute -Southfield | Southfield | Michigan | 48075 | — |
| Senders Pediatrics | South Euclid | Ohio | 44121 | — |
| REX Clinical Trials | Beaumont | Texas | 77701 | — |
| PanAmerican Clinical Research, LLC. | Brownsville | Texas | 78520 | — |
| South Ogden Family Medicine | South Ogden | Utah | 84403 | — |
| Clinical Research Partners | Richmond | Virginia | 23226 | — |
| Childrens Hospital Regional Medical Center | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07808697, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 8, 2026 · Synced Sep 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07808697 live on ClinicalTrials.gov.